Q2 2021 Holdings
Filed 2021-08-11 | 52 holdings | $96.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $17.8M | 135,000 | 18.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $15.8M | 205,000 | 16.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $13.0M | 1,600,000 | 13.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.3M | 32,500 | 11.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $9.5M | 285,000 | 9.9% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $7.2M | 275,000 | 7.4% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $6.8M | 600,000 | 7.0% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $6.1M | 200,000 | 6.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $4.6M | 243,309 | 4.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $4.4M | 250,000 | 4.5% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $40.6K | 300,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $18.1K | 570,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $16.1K | 185,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $15.8K | 850,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $15.0K | 875,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $14.6K | 700,000 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $12.1K | 1,250,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $11.7K | 450,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $8.1K | 50,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $7.0K | 180,000 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $6.5K | 1,000,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $6.4K | 350,000 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $6.4K | 904,225 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $6.3K | 2,000,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $6.1K | 450,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $5.9K | 207,500 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $5.5K | 125,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $5.2K | 500,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $5.2K | 75,000 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $4.9K | 170,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $4.6K | 725,000 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $4.3K | 1,000,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $4.0K | 1,600,000 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $3.9K | 200,000 | 0.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $3.5K | 125,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $3.3K | 145,000 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $3.2K | 265,000 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $3.1K | 800,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $2.6K | 265,000 | 0.0% |
| Immunovant Inc(IMVT)Call | COM | 45258J102 | $2.1K | 200,000 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $2.0K | 247,124 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $1.9K | 75,000 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $1.6K | 200,000 | 0.0% |
| Merus N V | COM | N5749R100 | $1.6K | 75,000 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $1.4K | 100,000 | 0.0% |
| Provention BIO Inc(PRVBUSD)Put | COM | 74374N102 | $1.3K | 150,000 | 0.0% |
| Casi Pharmaceuticals Inc(CASIEUR) | COM | 14757U109 | $1.0K | 650,000 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $1.0K | 450,000 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $982 | 100,000 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $940 | 4,000 | 0.0% |